Medication in the United States followed by Germany and the UAE is among the most expensive in the world to treat common but critical conditions such as heart disease to diabetes, according to a study. Authorities in the UAE have often slashed the prices of medicines and ask healthcare facilities to dispense generic versions instead of well-known brands to ease the burden on residents. Christopher Pike / The National
Medication in the United States followed by Germany and the UAE is among the most expensive in the world to treat common but critical conditions such as heart disease to diabetes, according to a study. Authorities in the UAE have often slashed the prices of medicines and ask healthcare facilities to dispense generic versions instead of well-known brands to ease the burden on residents. Christopher Pike / The National
Medication in the United States followed by Germany and the UAE is among the most expensive in the world to treat common but critical conditions such as heart disease to diabetes, according to a study. Authorities in the UAE have often slashed the prices of medicines and ask healthcare facilities to dispense generic versions instead of well-known brands to ease the burden on residents. Christopher Pike / The National
Medication in the United States followed by Germany and the UAE is among the most expensive in the world to treat common but critical conditions such as heart disease to diabetes, according to a study

Health

Safety alert as health ministry withdraws medicine from sale

The Ministry of Health and Prevention said a batch of Profinal failed to meet quality standards after tests

Ruba Haza
Ras Al Khaimah

February 26, 2019

  • English
  • Arabic

A pharmaceutical product widely used to treat fevers in children has been withdrawn from sale by the Ministry of Health and Prevention.

The ministry issued a circular on Monday recalling Profinal 100mg/5ml after laboratory tests found it failed to meet its quality standards.

The drug is used to reduce elevated body temperatures and offer pain relief for inflammatory conditions and is generally prescribed to children.

The product is manufactured by Julphar Gulf Pharmaceuticals, based in Ras Al Khaimah.

The safety notice, issued on the ministry's website, states that the product will be withdrawn from public and private health sectors and pharmacies with immediate effect.

The ministry also ordered all healthcare practitioners not to prescribe the medicine and urged members of the public to contact them immediately in case of any side effects caused by its use.

Read More

Ministry recalls some medicines containing valsartan over cancer fears

UAE supermarkets recall frozen food following killer listeria outbreak in Europe

Ras Al KhaimahUAE